Decisions / 4580
quality measure2020-11-20repealed

Maßnahmen zur Qualitätssicherung nach § 136a Absatz 5 SGB V: Onasemnogen-Abeparvovec bei spinaler Muskelatrophie

Open official decision page ↗

G-BA source · retrieved 2026-08-05

Decision orientation

What the G-BA did

3 cited claims

Each claim links to the official G-BA page or an exact PDF page range.

Official metadata

Decision date
2020-11-20
Effective
aufgehoben
Action type
quality measure
Committee
Arzneimittel

Case context

Listed normative targets

directiveATMP-Qualitätssicherungs-Richtlinie

A listed target is not treated as a new directive version unless an official version source exists.

Official document package